You are here

Drug Forecast

Abatacept (CTLA4-Ig, Orencia): An Investigational Biological Compound for the Treatment of Rheumatoid Arthritis

Payam Parchamazad, PharmD Candidate, Patty Ghazvini, PharmD, Marlon Honeywell, PharmD, and Phillip Treadwell, PharmD
PDF version: 
The authors review the benefits of abatacept (CTLA4-Ig, Orencia), an investigational compound for the treatment of rheumatoid arthritis.